A Phase II Trial Evaluating the Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Capecitabine; Carboplatin; Gemcitabine
- Indications Cancer
- Focus Therapeutic Use
- 10 Jan 2008 Biomarkers information updated
- 09 Jan 2008 Status changed from recuiting to discontinued.
- 15 Oct 2005 New trial record.